Lowest-Rated StocksLowest-RatedNYSE:BAX Baxter International (BAX) Stock Price, News & Analysis $26.37 -0.05 (-0.20%) Closing price 03:59 PM EasternExtended Trading$26.34 -0.03 (-0.12%) As of 04:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Baxter International Stock (NYSE:BAX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Baxter International alerts:Sign Up Key Stats Today's Range$25.98▼$26.5050-Day Range$22.79▼$26.4252-Week Range$15.73▼$30.00Volume3.82 million shsAverage Volume7.82 million shsMarket Capitalization$13.64 billionP/E RatioN/ADividend Yield0.15%Price Target$23.27Consensus RatingReduce Company Overview Baxter International is a global healthcare company that develops and supplies products used in hospitals, clinics and other care settings. Its offerings include intravenous solutions and administration sets, infusion pumps, medication-delivery systems, and products for surgical and hospital care. The company also provides patient-monitoring and connected-care technologies, including products associated with Hillrom, which Baxter acquired in 2021. Its products and services support healthcare professionals and patients in countries around the world. Founded in 1931, Baxter began by producing intravenous solutions. In 2025, it completed the separation of its kidney-care business, which became the independent company Vantive.AI Generated. May Contain Errors. Read More Baxter International Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks39th Percentile Overall ScoreBAX MarketRank™: 1.943971724045 of 5 starsBaxter International scored higher than 39% of companies evaluated by MarketBeat, and ranked 696th out of 897 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.9 / 5Analyst RatingReduce Consensus RatingBaxter International has received a consensus rating of Reduce. The company's average rating score is 1.86, and is based on no strong buy ratings, 1 buy rating, 10 hold ratings, and 3 sell ratings.Downside RiskBaxter International has a consensus price target of $23.27, representing about 12.0% downside from its current price of $26.45.Amount of Analyst CoverageBaxter International has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Baxter International's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings Growth-3.33% Earnings GrowthEarnings for Baxter International are expected to decrease by -3.33% in the coming year, from $2.10 to $2.03 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Baxter International is -18.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Baxter International is -18.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioBaxter International has a PEG Ratio of 3.89. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioBaxter International has a P/B Ratio of 2.11. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted4.58% of the float of Baxter International has been sold short.Short Interest Ratio / Days to CoverBaxter International has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Baxter International has recently decreased by 0.38%, indicating that investor sentiment is improving. Dividend0.8 / 5Dividend StrengthWeak Dividend YieldBaxter International has a dividend yield of 0.15%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthBaxter International does not have a long track record of dividend growth.Dividend SustainabilityBased on earnings estimates, Baxter International will have a dividend payout ratio of 1.97% next year. This indicates that Baxter International will be able to sustain or increase its dividend.Read more about Baxter International's dividend. News and Social Media4.4 / 5News Sentiment1.01 News SentimentBaxter International has a news sentiment score of 1.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.57 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 11 news articles for Baxter International this week, compared to 9 articles on an average week.Search Interest18 people have searched for BAX on MarketBeat in the last 30 days. This is an increase of 125% compared to the previous 30 days.MarketBeat Follows4 people have added Baxter International to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Baxter International insiders have not sold or bought any company stock.Percentage Held by Insiders0.17% of the stock of Baxter International is held by insiders.Percentage Held by Institutions90.19% of the stock of Baxter International is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Baxter International's insider trading history. Receive BAX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Baxter International and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BAX Stock News HeadlinesBaxter International (NYSE:BAX) Stock Price Target Raised at BarclaysNovember 10 at 4:27 AM | americanbankingnews.comLENSAR (NASDAQ:LNSR) & Baxter International (NYSE:BAX) Critical ComparisonNovember 9 at 2:15 AM | americanbankingnews.comTrump’s EO to send this $5 stock ripping higher…?President Trump's December executive order declared space a national security and economic priority, fueling a race among SpaceX, Blue Origin, and others to build massive satellite constellations. One tiny firm holds the patented tech required to transmit satellite data to Earth at scale - and it reportedly powers SpaceX's most profitable division. Shares trade for under 5 dollars. Former JPMorgan wealth manager Ross Givens says it's the most uniquely positioned stock he's seen in 20 years of trading.November 11 at 1:00 AM | Traders Agency (Ad)How Return To Profit Will Impact Baxter International Stock (BAX)November 6, 2026 | finance.yahoo.comShould You Buy Baxter Stock For Its Cash?November 5, 2026 | finance.yahoo.comBaxter International Stock: Analyst Estimates & RatingsNovember 4, 2026 | barchart.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Baxter International (BAX) and Alphatec Holdings (ATEC)November 1, 2026 | theglobeandmail.comBaxter International (BAX) Gets a Sell from BarclaysOctober 31, 2026 | theglobeandmail.comSee More Headlines BAX Stock Analysis - Frequently Asked Questions How have BAX shares performed this year? Baxter International's stock was trading at $19.12 at the start of the year. Since then, BAX stock has increased by 38.3% and is now trading at $26.4450. How were Baxter International's earnings last quarter? Baxter International Inc. (NYSE:BAX) released its quarterly earnings results on Thursday, October, 29th. The medical instruments supplier reported $0.58 earnings per share for the quarter, topping the consensus estimate of $0.52 by $0.06. Baxter International's revenue for the quarter was up 5.0% on a year-over-year basis. Read the conference call transcript. Does Baxter International have any subsidiaries? Baxter International subsidiaries include Cheetah Medical, ApaTech Limited, Baxter AO, Baxter Belgium SPRL, Baxter (China) Investment Co. Ltd, Baxter Company Ltd, Baxter Corporation (Canada), and more. Who are Baxter International's major shareholders? Baxter International's top institutional investors include Pzena Investment Management LLC (12.07%), Equity Investment Corp (1.27%), Aberdeen Group plc (0.72%) and Russell Investments Group Ltd. (0.68%). View institutional ownership trends. How do I buy shares of Baxter International? Shares of BAX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Baxter International own? Based on aggregate information from My MarketBeat watchlists, some other companies that Baxter International investors own include Johnson & Johnson (JNJ), Pfizer (PFE), Intel (INTC), Cisco Systems (CSCO), Verizon Communications (VZ), Abbott Laboratories (ABT) and Merck & Co., Inc. (MRK). Company Calendar Record date for 10/1 Dividend8/28/2026Ex-Dividend for 10/1 Dividend8/28/2026Dividend Payable10/01/2026Last Earnings10/29/2026Today11/11/2026Record date for 1/4 Dividend11/27/2026Ex-Dividend for 1/4 Dividend11/27/2026Fiscal Year End12/31/2026Dividend Payable1/04/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1w+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 For the last 9 days, BAX's financial health has been in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNYSE:BAX CIK10456 Webwww.baxter.com Phone(224) 948-2000Fax224-948-1813Employees37,500Year Founded1931Price Target and Rating Average Price Target for Baxter International$23.27 High Price Target$27.00 Low Price Target$15.00 Potential Upside/Downside-11.7%Consensus RatingReduce Rating Score (0-4)1.86 Research Coverage14 Analysts Profitability EPS (Trailing Twelve Months)($1.41) Trailing P/E RatioN/A Forward P/E Ratio12.99 P/E Growth3.89Net Income-$957 million Net Margins-6.23% Pretax Margin-1.61% Return on Equity16.23% Return on Assets5.08% Debt Debt-to-Equity Ratio1.20 Current Ratio1.79 Quick Ratio1.19 Sales & Book Value Annual Sales$11.24 billion Price / Sales1.21 Cash Flow$5.68 per share Price / Cash Flow4.64 Book Value$12.52 per share Price / Book2.11Miscellaneous Outstanding Shares517,350,000Free Float516,469,000Market Cap$13.64 billion OptionableOptionable Beta0.68 Social Links The 7 Best High-Yield Dividend Stocks for 2027Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.Get This Free Report This page (NYSE:BAX) was last updated on 11/11/2026 by MarketBeat.com Staff. From Our PartnersHas The AI Bubble Popped?A recent sell-off wiped $2.3 trillion off the Nasdaq 100 in a single day, leaving Wall Street split on whether...Porter & Company | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredTrump’s EO to send this $5 stock ripping higher…?President Trump's December executive order declared space a national security and economic priority, fueling a...Traders Agency | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredUranium Mine Flood That Sparked a 2006 Price Surge ReturnsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...Digest Publishing | SponsoredDon't lose access to thisIan Cooper is giving away his guide, The Simple Path To Success With Options, before it moves behind a paywall...TradeWins | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Baxter International Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Baxter International With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
